Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > My opinion

<< Previous

Bullboard Posts

Next >>

Comment by Duster340on Jul 23, 2022 12:22am

111 Views

Post# 34845006

RE:RE:RE: My opinion

Mmmtroll wrote:
you're mad because you asked mgmt to do somethig illegal and they didn't respond. Hahahahaha dumpster you certainly a moron. Sell me your 300 shares. I'll buy them at 80c. Then do us all a favor and never post here again

Duster340 Writes: why would i be mad, by them not responding to some of my questions i partially got the answer i was looking for. the truth is some of my questions were answered, and i will keep that info to myself. clearly you are not the sharpest tool in the shed asking questions has never been ilegal, you must live in the same universe as dav/pez/check

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project